Old Mission Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24M | Buy |
435,091
+275,181
| +172% | +$14.9M | 0.57% | 35 |
|
|
2025
Q4 | $7.84M | Buy |
+159,910
| New | +$7.46M | 0.3% | 61 |
|
|
2024
Q4 | – | Sell |
-332,093
| Closed | -$13.6M | – | 1031 |
|
|
2024
Q3 | $13.6M | Sell |
332,093
-60,314
| -15% | -$2.47M | 0.3% | 96 |
|
|
2024
Q2 | $15.1M | Buy |
392,407
+114,782
| +41% | +$4.83M | 0.4% | 74 |
|
|
2024
Q1 | $11.9M | Buy |
277,625
+77,994
| +39% | +$3.22M | 0.29% | 91 |
|
|
2023
Q4 | $7.4M | Buy |
199,631
+122,794
| +160% | +$4.41M | 0.21% | 133 |
|
|
2023
Q3 | $2.79M | Buy |
+76,837
| New | +$2.73M | 0.09% | 244 |
|
|
2023
Q1 | – | Sell |
-39,413
| Closed | -$1.38M | – | 1552 |
|
|
2022
Q4 | $1.38M | Buy |
+39,413
| New | +$1.31M | 0.06% | 407 |
|
|
2022
Q3 | – | Sell |
-72,449
| Closed | -$3.94M | – | 1115 |
|
|
2022
Q2 | $3.94M | Buy |
72,449
+13,380
| +23% | +$739K | 0.13% | 175 |
|
|
2022
Q1 | $3.22M | Buy |
+59,069
| New | +$3.21M | 0.1% | 199 |
|
|
2021
Q1 | – | Sell |
-33,572
| Closed | -$1.54M | – | 791 |
|
|
2020
Q4 | $1.54M | Sell |
33,572
-21,467
| -39% | -$986K | 0.1% | 184 |
|
|
2020
Q3 | $2.59M | Sell |
55,039
-251,445
| -82% | -$12.6M | 0.2% | 117 |
|
|
2020
Q2 | $15.6M | Buy |
+306,484
| New | +$15.7M | 1.12% | 12 |
|
|
2020
Q1 | – | Sell |
-352,053
| Closed | -$20.7M | – | 429 |
|
|
2019
Q4 | $20.7M | Buy |
352,053
+66,089
| +23% | +$3.68M | 1.59% | 14 |
|
|
2019
Q3 | $15.3M | Buy |
285,964
+56,868
| +25% | +$2.93M | 1.9% | 7 |
|
|
2019
Q2 | $11.5M | Buy |
229,096
+188,319
| +462% | +$9.45M | 1.44% | 10 |
|
|
2019
Q1 | $2.13M | Buy |
+40,777
| New | +$2.04M | 0.36% | 57 |
|
|
2018
Q3 | – | Sell |
-52,695
| Closed | -$2.65M | – | 293 |
|
|
2018
Q2 | $2.65M | Sell |
52,695
-1,185
| -2% | -$59.7K | 0.29% | 47 |
|
|
2018
Q1 | $2.63M | Sell |
53,880
-53,845
| -50% | -$2.51M | 0.36% | 53 |
|
|
2017
Q4 | $4.78M | Buy |
+107,725
| New | +$4.98M | 0.31% | 58 |
|
|
2017
Q3 | – | Sell |
-19,599
| Closed | -$1.06M | – | 369 |
|
|
2017
Q2 | $1.06M | Buy |
+19,599
| New | +$1.04M | 0.13% | 113 |
|
|
2017
Q1 | – | Sell |
-102,138
| Closed | -$4.92M | – | 392 |
|
|
2016
Q4 | $4.92M | Buy |
+102,138
| New | +$5.05M | 0.38% | 48 |
|
|
2016
Q2 | – | Sell |
-15,481
| Closed | -$785K | – | 338 |
|
|
2016
Q1 | $785K | Buy |
+15,481
| New | +$771K | 0.08% | 134 |
|
|
2015
Q1 | – | Sell |
-45,806
| Closed | -$2.45M | – | 246 |
|
|
2014
Q4 | $2.45M | Buy |
+45,806
| New | +$2.56M | 0.44% | 44 |
|
Other funds holding GSK
JEST
